Oaktree Acquisition Corp. III Life Sciences (OACCW) Total Return Calculator with Dividends Reinvested

Oaktree Acquisition Corp. III Life Sciences

Popular:

The total return for Oaktree Acquisition Corp. III Life Sciences (OACCW) stock is +6.49% over the past 12 months. So far it's down 11.64% this year. The 5-year total return is +6.49%, meaning $10,000 invested in OACCW stock 5 years ago would be worth $10,649 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in OACCW 1 year ago, it would be worth $10,649 today — you'd have gained $649.

With Dividends Reinvested$10,649+6.49%

Price Only (No DRIP)$10,649+6.49%

Period2025-09-15 → 2026-06-16

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in OACCW

1Y$10,649+$649 (+6.5%)6.5% CAGR

3Y$10,649+$649 (+6.5%)2.1% CAGR

5Y$10,649+$649 (+6.5%)1.3% CAGR

10Y$10,649+$649 (+6.5%)0.6% CAGR

15Y$10,649+$649 (+6.5%)0.4% CAGR

20Y$10,649+$649 (+6.5%)0.3% CAGR

30Y$10,649+$649 (+6.5%)0.2% CAGR

Oaktree Acquisition Corp. III Life Sciences did not pay dividends during this period. Total return = price return.

Loading OACCW total return...

As of 2026-06-23

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-11.64%	—	-11.64%	—	$8,836
1Y	+6.49%	6.49%	+6.49%	—	$10,649
3Y	+6.49%	2.12%	+6.49%	—	$10,649
5Y	+6.49%	1.27%	+6.49%	—	$10,649
10Y	+6.49%	0.63%	+6.49%	—	$10,649
15Y	+6.49%	0.42%	+6.49%	—	$10,649
20Y	+6.49%	0.32%	+6.49%	—	$10,649
30Y	+6.49%	0.21%	+6.49%	—	$10,649

Risk & Highlights

Best Year-7.79%2025

Max Drawdown-72.22%2025-11-17 → 2026-04-10

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-19.18%	-19.18%	—	+0.41%	-19.6pp
2025	-7.79%	-7.79%	—	+16.64%	-24.4pp

OACCW underperformed the S&P 500 by 18.50pp over the past year (+6.49% vs +24.99%).

Loading summary...

OACCW Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
OACCWOaktree Acquisition Corp. III Life Sciences	$16M	+9.2%	-11.6%	+6.5%	—	+6.5%	+6.5%	+6.5%
RLAYRelay Therapeutics, Inc.	$3.3B	+31.2%	+94.1%	+372.6%	—	+31.0%	-55.1%	-54.7%
RXRXRecursion Pharmaceuticals, Inc.	$1.4B	+11.8%	-23.1%	-36.8%	—	-64.0%	-91.1%	-82.1%
BCTXBriaCell Therapeutics Corp.	$6M	-13.4%	-59.6%	-90.7%	—	-99.7%	-99.6%	—
IPODDune Acquisition Corporation II	$151M	+0.8%	+2.2%	+4.3%	—	+4.1%	+4.1%	+4.1%
BXBlackstone Inc.	$96.6B	+5.7%	-20.4%	-6.4%	+3.6pp	+50.2%	+50.0%	+511.0%
KKRKKR & Co. Inc.	$86.4B	+1.1%	-24.4%	-20.1%	+0.6pp	+75.1%	+78.0%	+708.3%
APOApollo Global Management, Inc.	$78.0B	+2.6%	-5.5%	+4.9%	+1.6pp	+87.5%	+155.7%	+917.6%
CGThe Carlyle Group Inc.	$16.1B	-3.9%	-25.2%	-1.8%	+3.0pp	+56.2%	+16.4%	+266.3%
ARESAres Management Corporation	$41.3B	+4.6%	-20.6%	-19.8%	+3.0pp	+51.8%	+156.5%	+1055.7%
TPGTPG Inc.	$15.8B	+1.7%	-34.2%	-11.3%	+4.5pp	+59.9%	+45.2%	+45.2%

Compare:OACCW vs RLAY OACCW vs RXRX OACCW vs BCTX OACCW vs RLAY vs RXRX

About OACCW Dividend Returns

Oaktree Acquisition Corp. III Life Sciences (OACCW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of OACCW over the past year?

Oaktree Acquisition Corp. III Life Sciences (OACCW) delivered a return of 6.49% over the past year. Since OACCW does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in OACCW be worth today?

A $10,000 investment in Oaktree Acquisition Corp. III Life Sciences one year ago would be worth $10,649 today, representing a gain of $649.

Q3Does OACCW pay dividends?

Oaktree Acquisition Corp. III Life Sciences (OACCW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For OACCW, the total return equals the price-only return.

Q4Did OACCW beat the S&P 500?

No, Oaktree Acquisition Corp. III Life Sciences (OACCW) underperformed the S&P 500 by 18.50 percentage points over the past year. OACCW delivered a total return of 6.49%, compared to the S&P 500's 24.99%. This means a passive S&P 500 index fund outperformed OACCW by 18.50pp during this period.

Q5What is OACCW's worst drawdown?

Oaktree Acquisition Corp. III Life Sciences (OACCW) experienced a maximum drawdown of -72.22% over the past year, declining from its peak on 2025-11-17 to its trough on 2026-04-10. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is OACCW's long-term total return over 10, 20, or 30 years?

Here are Oaktree Acquisition Corp. III Life Sciences (OACCW)'s long-term returns with dividends reinvested. Over 10 years, the total return is 6.5% (0.6% CAGR) — $10,000 would have grown to $10,649. Over 20 years: 6.5% total return (0.3% CAGR) — $10,000 → $10,649. Over 30 years: 6.5% total return (0.2% CAGR) — $10,000 → $10,649. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

How much would $100/month in OACCW be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →